NCT00610168View on ClinicalTrials.gov

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 1, 2008

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Acellular PertussisTetanusDiphtheria
Interventions
BIOLOGICAL

Boostrix TM

Single booster dose of vaccine

Trial Locations (1)

20520

GSK Investigational Site, Turku

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY